Organization · Venture Capital
NGT
NGT HealthCare II is an early-stage venture capital fund and technology incubator based in Nazareth, Israel, focusing on medical devices and life sciences. The organization emphasizes social impact and supports Arab entrepreneurs within Israel's healthcare startup ecosystem.
Overview
What NGT does
What NGT is
NGT HealthCare II is an early-stage venture capital fund and technology incubator based in Nazareth, Israel, focusing on medical devices and life sciences. The organization emphasizes social impact and supports Arab entrepreneurs within Israel's healthcare startup ecosystem.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find NGT elsewhere
Open the official website or a supported primary organization account.
Capability profile
NGT as a funder
Investment thesis
NGT invests in early-stage medical and life-sciences technologies where technical risk can be reduced through Israel Innovation Authority support, university/hospital deal flow, and industry partnerships. The fund promotes equal opportunity for Arab entrepreneurs and cultivates healthcare entrepreneurship in Northern Israel.
Focus narrative
NGT invests in early-stage medical device and life sciences technologies, with a commitment to creating social impact while delivering financial returns. The fund actively supports Arab entrepreneurs and promotes inclusion within Israel's medical startup ecosystem, aiming to foster economic growth and social mobility in the Northern periphery of Israel.
Value beyond capital
NGT provides significant value to its portfolio companies through access to non-dilutive funding, strong industry connections, and support from leading universities and hospitals. The fund's focus on social impact and inclusion fosters a collaborative environment that enhances innovation and growth potential for startups.
Focus and fit
- Stages
- Pre-seed · Seed · Friends and Family · Angel
- Sectors
- Healthcare · Biotech · Medical Devices
- Regions
- North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Prolor Biotech, Mazor Robotics, ReWalk, and Corindus
Portfolio context
NGT's portfolio includes notable companies such as: Prolor Biotech: Sold to OPKO for $480 million. Mazor Robotics: Sold to Medtronic for $1.6 billion. ReWalk: Listed on NASDAQ (RWLK). Corindus: Sold to Siemens for $1.1 billion. Ark Surgical: Focused on safer women's surgery with FDA-cleared products. UB Therapeutics: Developing cyclic peptide therapies for multiple myeloma. Kailo Pharma: Developing a nasal-spray PTSD treatment.
Common questions
What to know about NGT
Upseed classifies NGT under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.